Immediate Impact
2 from Science/Nature 77 standout
Citing Papers
Optimized inhaled LNP formulation for enhanced treatment of idiopathic pulmonary fibrosis via mRNA-mediated antibody therapy
2024 Standout
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis
2024 Standout
Works of K.M. Beeh being referenced
Benefits of omalizumab as add‐on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE
2004 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| K.M. Beeh | 644 | 822 | 420 | 10 | 868 | |
| T.F. Reiss | 761 | 909 | 317 | 10 | 1000 | |
| K. Surrey | 797 | 1080 | 637 | 9 | 1.1k | |
| Philippe Godard | 683 | 724 | 146 | 12 | 889 | |
| Carlos Fernández Vidaurre | 444 | 601 | 351 | 7 | 850 | |
| A M Vignola | 538 | 630 | 255 | 13 | 784 | |
| Gun Almqvist | 419 | 721 | 247 | 16 | 879 | |
| L Schwartz | 260 | 513 | 202 | 11 | 892 | |
| Leen Gilles | 401 | 421 | 124 | 15 | 1000 | |
| Yanping Wu | 609 | 899 | 246 | 14 | 970 | |
| Sabine Kony | 350 | 409 | 254 | 14 | 881 |
All Works
Loading papers...